Research and Markets - Global Human Albumin Market 2016-2020 with CSL Behring, Grifols, Baxalta, Octapharma & Kedrion Dominating

DUBLIN, July 19, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Human Albumin Market 2016-2020" report to their offering.

The analysts forecast the global human albumin market to grow at a CAGR of 4.97% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global human albumin market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic albumin drugs used to treat infections, liver diseases, shock, during surgery, and severe burns. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.

Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period.

A trend helping to propel market growth is the rise in non-therapeutic applications. Non-therapeutic applications of albumin are on a rise. Research is yet to evaluate the applications of albumin as an excipient for commercial use. Some areas where albumin can be employed are as a drug-formulating agent, an ingredient in vaccines and sealant in surgeries, and to coat medical devices and equipment. Though the current supply of albumin for non-therapeutic purposes is low, the high interest shown by the research institutes and pharmaceutical and biopharmaceutical companies in investigating the potential non-therapeutic uses of albumin is expected to drive the market.

According to the report, a key driver is the high demand for human albumin in China. China is the largest market for albumin products. Albumin is being used as a volume replacement therapy and for treating kidney diseases, cirrhosis, and cancer. But the demand for plasma products, primarily albumin and immunoglobulins, is outstripping the supply. This is because of the stringent regulations imposed on the supply of raw materials and ban in the import of plasma products. Because of the increased demand for albumin products, the ban on import of plasma products did not include albumin

Further, the report states that one challenge that could curtail market growth is the spread of pathogenic contaminants.

Key vendors

- CSL Behring
- Grifols
- Baxalta
- Octapharma
- Kedrion

Other prominent vendors

- AADi
- Ablynx
- Albumedix
- Ampio Pharmaceuticals
- Azaya Therapeutics
- Beijing Tiantan
- Biotest
- Bristol-Myers Squibb
- Celgene
- ConjuChem
- GSK
- Hebei Changshan Biochem Pharma
- HiMedia Laboratories
- Hualan Biological Engineering
- InVittria
- MedxBio
- Merck
- Mitsubishi Tanabe Pharma
- NantBioScience
- Novo Nordisk
- Novozymes
- Shanghai RAAS Blood Products
- Sucampo Pharmaceuticals
- Teva Pharmaceuticals
- Thermo Fisher Scientific
- Tianjin SinoBiotech & Beijing Bio-Fortune
- Ventria Bioscience
- Yoshitomi Pharmaceutical 

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Plasma therapeutics: An overview

Part 06: Global plasma therapeutics market

Part 07: Plasma fractionation market

Part 08: Albumin: An overview

Part 09: Pipeline portfolio

Part 10: Global albumin market

Part 11: Market landscape

Part 12: Market segmentation by application

Part 13: Geographical segmentation

Part 14: China albumin market

Part 15: Market drivers

Part 16: Impact of drivers

Part 17: Market challenges

Part 18: Impact of drivers and challenges

Part 19: Market trends

Part 20: Vendor landscape

Part 21: Appendix

For more information visit http://www.researchandmarkets.com/research/jx49v3/global_human

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets